Novavax vaccine is 89% effective against COVID-19 in U.K. study

Read MoreNovavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study.Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study.